4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-21-021293
Chief Medical Officer sold 13,439 shares at an average $15.10 ($202,894)
- Chief Medical Officer acquired 13,439 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pienta Kenneth · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 1 in the form | +13,000 | $5.00 | $65,000 | 15,000 | D |
| 2021-03-15 | Sale : show line 2 in the form | −13,000 | $15.10 | $196,269 | 2,000 | D |
| 2021-03-16 | Exercise or conversion : show line 3 in the form | +439 | $5.00 | $2,195 | 2,439 | D |
| 2021-03-16 | Sale : show line 4 in the form | −439 | $15.09 | $6,626 | 2,000 | D |
| Open-market sales · 13,439 sh · avg $15.10 · $202,894 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −13,000 | 134,006 | D |
| 2021-03-16 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −439 | 133,567 | D |
Loading xslF345X03/doc4.xml…